Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human urinary kallidinogenase for cerebral blood flow recovery after acute ischemic stroke
ChiCTR-OPN-15007508Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jan 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Human urinary kallidinogenase in ischemic stroke and brain infarction (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: National Institutes of Health Stroke Scale, modified Rankin Scale and 4 more. Started Jan 2010; status: recruiting.
02
Drugs
Human urinary kallidinogenase
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR-OPN-15007508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15007508.